These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, Ladenheim EE. Am J Physiol Regul Integr Comp Physiol; 2005 Feb; 288(2):R384-8. PubMed ID: 15388494 [Abstract] [Full Text] [Related]
13. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner. Hata T, Mera Y, Ishii Y, Tadaki H, Tomimoto D, Kuroki Y, Kawai T, Ohta T, Kakutani M. J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060 [Abstract] [Full Text] [Related]
15. Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats. Chelikani PK, Haver AC, Reeve JR, Keire DA, Reidelberger RD. Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R298-305. PubMed ID: 16210414 [Abstract] [Full Text] [Related]
16. Role of peptide YY(3-36) in the satiety produced by gastric delivery of macronutrients in rats. Reidelberger R, Haver A, Chelikani PK. Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E944-50. PubMed ID: 23482449 [Abstract] [Full Text] [Related]
17. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL. Endocrinology; 2005 Sep 01; 146(9):3748-56. PubMed ID: 15932924 [Abstract] [Full Text] [Related]